Mirae Asset Global Investments Co., Ltd. Kura Oncology, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,591 shares of KURA stock, worth $21,453. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,591
Previous 2,772
6.53%
Holding current value
$21,453
Previous $54,000
59.26%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding KURA
# of Institutions
196Shares Held
79.6MCall Options Held
98.7KPut Options Held
70.1K-
Black Rock Inc. New York, NY6.97MShares$57.7 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.8MShares$48 Million0.71% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.08MShares$42 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.82MShares$39.9 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.45MShares$36.9 Million0.63% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $554M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...